Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CRTC1
REST API REST API
Homo sapiens
CRTC1 is differentially expressed in 190 experiments: 128 organism parts: cerebellum, amygdala, ... (126 more);, 168 disease states: normal, colorectal adenocarcinoma, ... (166 more);, 57 cell types 245 cell lines 25 compound treatments and 66 other conditions.
Synonyms FLJ14027, MECT1, TORC1, KIAA0616
Orthologs Q0V8A0_BOVIN (Bos taurus)   CRTC1 (Gallus gallus)   CRTC1 (2 of 2) (Danio rerio)   CRTC1 (1 of 2) (Danio rerio)   ENSCING00000013531 (Ciona intestinalis)   Crtc1 (Mus musculus)   Crtc1 (Rattus norvegicus)   crtc1 (Xenopus laevis)   CRTC1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term plasma membrane, protein binding, regulation of transcription, DNA-dependent, cytoplasm, cAMP response element binding protein binding, positive regulation of transcription from RNA polymerase II promoter, nucleus, interspecies interaction between organisms
UniProt Accession Q6UUV9
Search EB-eye ENSG00000105662
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-MEXP-1251, E-MTAB-24, ... (21 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-22639, E-GEOD-19639, E-GEOD-18005, ... (21 experiments)

Factor Value U/D Experiments
BT-474
2
E-GEOD-5823, E-GEOD-3529
MCF-7
1
2
E-GEOD-20081, E-GEOD-5823, E-GEOD-3529
769P
1
1
E-MTAB-37
ssMCF7
1
E-GEOD-5258
REC
1
E-MTAB-62
NCIH1666
1
E-MTAB-37
239 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-3920, E-MEXP-750, E-GEOD-20677, E-GEOD-13909, ... (30 experiments)

Factor Value U/D Experiments
CD4+ T cell
1
2
8
E-AFMX-5, E-TABM-145, E-MTAB-24
n/a
1
E-MTAB-24
CD8+ T cell
1
E-MTAB-25
liver cancer
1
E-GEOD-21154
effector memory CD4 T cell
1
E-MEXP-750
B cell
3
1
E-GEOD-13987
51 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-1615, E-GEOD-15960, E-GEOD-1869, E-MEXP-2069, ... (46 experiments)

Factor Value U/D Experiments
embryonal rhabdomyosarcoma
2
E-MTAB-62, E-MEXP-121
esophageal carcinoma
1
E-MTAB-37
Calpain 3 mutation
1
E-GEOD-3307
CLL (Chronic Lymphocytic Leukemia)
1
E-GEOD-16455
metabolic syndrome
1
E-MTAB-62
progressive supranuclear palsy
1
E-MEXP-2280
162 more value(s).


Compound treatment

studied in E-GEOD-15205, E-TABM-782, E-GEOD-5824, E-GEOD-5099, E-GEOD-5339, ... (14 experiments)

Factor Value U/D Experiments
vanadium pentoxide
1
E-GEOD-5339
unknown
1
E-GEOD-7307
TNF
1
1
E-GEOD-15205
filtered air
1
E-TABM-127
selenium
1
E-MEXP-1327
4-hydroxytamoxifen
1
1
E-MEXP-2241
19 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-GEOD-1729

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (7 experiments)

Clinical info
studied in E-MTAB-37, E-MEXP-1251, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-2666, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-3325, E-TABM-147, E-GEOD-21138

Environmental stress
studied in E-GEOD-1518

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482

Genotype
studied in E-GEOD-17476, E-MEXP-421

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1103

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-MEXP-2069, E-TABM-26, E-GEOD-16363, E-GEOD-430, ... (26 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-GEOD-17400

Injury
studied in E-GEOD-19743

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-MEXP-958

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-GEOD-2004

Phenotype
studied in E-GEOD-1309

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Progression free survival of days
studied in E-GEOD-5851

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (6 experiments)

RNAi
studied in E-MEXP-1509, E-MEXP-101, E-GEOD-3697

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-19815

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271

Vehicle
studied in E-GEOD-5258

Processing time: 0.264 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM